Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00899457 · ClinicalTrials.gov registry record

Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants

A clinical trial of Lung Cancer and Healthy, no Evidence of Disease, sponsored by Vanderbilt-Ingram Cancer Center.

Completed
Registry status
37
Enrollment target
3
Study locations

NCT00899457 is a study of Lung Cancer and Healthy, no Evidence of Disease that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 37 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00899457, a study of Lung Cancer and Healthy, no Evidence of Disease, has completed, sponsored by Vanderbilt-Ingram Cancer Center.

COMPLETED
Registry status
37 participants
Enrollment target
3
Study locations

Study Summary

RATIONALE: Studying samples of blood, urine, sputum, mouth cells, and bronchial tissue from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors learn more about the development of cancer. PURPOSE: This laboratory study is looking for molecular markers in predicting lung cancer development using tissue samples from healthy participants.

Conditions Studied

Lung Cancer Healthy, no Evidence of Disease

Interventions

  • OTHER biologic sample preservation procedure
  • OTHER laboratory biomarker analysis
  • PROCEDURE bronchoscopy
  • GENETIC proteomic profiling

Study Locations (3)

Tennessee

  • Vanderbilt-Ingram Cancer Center - Cool Springs - Nashville
  • Vanderbilt-Ingram Cancer Center at Franklin - Nashville
  • Vanderbilt-Ingram Cancer Center - Nashville

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2008-04
Est. Completion 2010-08

Sponsor

Vanderbilt-Ingram Cancer Center

189 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00899457

The ClinicalTrials.gov registry entry for NCT00899457 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which biologic sample preservation procedure is the first listed.

NCT00899457 reports 3 study locations spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00899457 about?

NCT00899457 is a clinical study titled "Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants". RATIONALE: Studying samples of blood, urine, sputum, mouth cells, and bronchial tissue from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors learn more about the development of cance...

What is the current status of trial NCT00899457?

This trial is currently completed. The enrollment target is 37 participants. The study started on 2008-04. Estimated completion is 2010-08.

What conditions does trial NCT00899457 study?

This clinical trial studies the following conditions: Lung Cancer, Healthy, no Evidence of Disease.

What interventions are being tested in trial NCT00899457?

The interventions under investigation include: biologic sample preservation procedure (OTHER), laboratory biomarker analysis (OTHER), bronchoscopy (PROCEDURE), proteomic profiling (GENETIC).

Who is sponsoring clinical trial NCT00899457?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00899457 being conducted?

This trial has 3 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Healthy, no Evidence of Disease

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.